We would love to hear your thoughts about our site and services, please take our survey here.
Genedrive has ZERO debt.
If they get a lowball cheap Buy Out offer of £50m or £100m
Sale proceeds go to SHAREHOLDERS coz there are NO DEBT HOLDERS.
Public or Private is red herring and Offtopic.
RF is on the way out.
If they exercise their warrants that would be upwards of +10p.
Expecting positive updates next week pushing price upwards towards +15p before RF exercise their warrants when they are in the money.
Funds can be raised easily from Riverfort exercising their warrants.
Lowest warrants Exercise price @ 10.86p if i am not mistaken.
Plus we got £1.5m cash currently. No need for significant funds to be raised immediately as some keep spouting for their own agenda.
With STROKE tests RNS earlier this week, Genedrive would become even more attractive to any US partner coming in with 2 leading products under their wings.
Valuation equation has changed a lot in GDR favour now compared to few months ago.
Yes. He has an impressive track record.
2024 looking to be pivotal year for Genedrive after many years of product development. Genedrive finally on the cusp of some juicy ROI for holders.
The Company will provide a live presentation to accompany the results, presented by Chief Executive Officer James Cheek, Chief Financial Officer Russ Shaw and Chief Scientific Officer Gino Miele, on Friday, 5 April 2024 at 10.00am.
The presentation will be hosted through the digital platform Investor Meet Company. Investors can sign up to Investor Meet Company for free and add to meet genedrive plc via the following link: https://www.investormeetcompany.com/genedrive-plc/register-investor
That is 52% of the entire issued Share Capital.
18 x daily average of 2m shares....wow
Wadogara.
Strong momentum brings superb gains as we have seen in the past here at Genedrive.
Speculation yes but that is what we all do. With 2 great products backed now by NICE recommendations, starting to get markets attention and pharma industry players.
Taken Genedrive years to get to this point with 2024 shaping up to be pivotal year for holders.
With only 150m odd shares about, moves here can be fast n furious. I can handle the volatility with eye on the prize and end game here which could also lead to early BuyOut offer for the company. Speculation yes - otherwise we will not be here.
Word Funding is not "Taboo". Even big Multi-national cos raise funds for expansion & growth.
Few scenarios below:
1) Incoming US pharma partner invests upfront cash for future sales royalties from US sales.
2) Incoming partner invests a large sum for % Equity stake in Genedrive.
3) Genedrive raise e.g. £4m around 12p when price is mid Double digits and removing any uncertainty with a clear run to 40p - 50p and higher.
Agree 100%. If RF were not busy selling their last tranche of shares yesterday we would have hit 10p yesterday.
Expect this to go lot higher on strong momentum in coming weeks. Biggest price gains come from strong momentum and higher volumes which traders love. Current MCap is ridiculously low.
This was around 43p last year before RF deal.
RF now on the way out and both AIHL and STROKE tests gaining traction with NICE recommendations, this can easily get back to 43p and beyond that in 2024.
Interesting to note:
Exercise price of warrants that RF would have to pay to Genedrive is 10.86p as per previous RNS
Yes 1.5p is jus the nominal value of shares. You can ignore that.
Amazing Volume today..almost 18 times daily avg
Good to see Riverfort out now after selling their last tranch today on HIGH VOLUME day.
Agree. £100m MCap would be at very low end.
I see GDR gaining lot more traction. Need to stay with it. Genedrive could give you biggest ROI this year in my opinion.
Popeye....time for some Spinach mate 😁
Lot of folk running with their own strategy.
Wih FDA update so close, this could really take off towards +20p. They can raise funds then at 15p or higher.
Expect an even bigger push higher after that.
Lot of "Doom" merchants suddenly show up trying to get in cheaper....way too obvious.
We funded via Riverfort for another 4 months.
FDA partner funding talks in progress already. Incoming US partner could also pay upfront Cash for lets say 5% - 10% equity stake in GDR. Lot of options available especially after todays Transformational news on STROKE test recommendation by NICE. You can also have bigger Industry players looking to get in also as early investors in GDR.
They will have the option to raise funds may be in 3 months time in high DOUBLE DIGITS after further pending positive news and clear out Riverfort for good.
Just wait till FUND MANAGERS start taking positions both in the UK and USA.
FDA update should start the party here BIG TIME.
Yes nissangtr. Agree with you. We have seen many times GDR move at lightning speed with low number of shares about.
I remember when GDR rocketed from 10p to 80p in just over a week when Market piled in 2 yrs ago
Agree. Far too cheap.
Was 27.2p last year on 3 Apr 2023 (80% down).
With todays "Transformational" news on STROKE test recommendation by NICE is a MASSIVE endorsement for Genedrive to regain its GLORY.
BIG PHARMA would be watching further developments here for sure given STROKE test market is worth Multi-Billion $$$ worldwide.
Artemis (ARV) is significantly undervalued on any metric given its prime location and recent discoveries on some highly prospective ground next to proven discoveries.
In due course even 11.2p would look mega cheap.